These findings suggest that high infiltration of MCT1+CD163+ macrophages in the tissue is not superior to high infiltration of MCT1+CD163+ macrophages in the margin for the prediction of breast cancer progression. The gene discussed is SLC16A1; the disease is breast carcinoma.